Aptose Biosciences company info

What does Aptose Biosciences do?
Aptose Biosciences (TSX:APS), (NASDAQ:APTO) is a biotechnology firm focused on developing personalized therapies to address unmet medical needs in oncology, particularly in the treatment of life-threatening cancers. Aptose Biosciences operates with a keen eye on innovative research to advance the development of its pipeline products, which are designed to target the underlying mechanisms of cancer. The company is dedicated to pushing the boundaries of science to bring forward novel treatments that can offer better outcomes for patients battling cancer. Their objectives revolve around progressing their clinical trials, securing strategic partnerships, and advancing their research to bring transformative cancer therapies to the market.
Aptose Biosciences company media
Company Snapshot

Is Aptose Biosciences a public or private company?

key
Ownership
Public

How many people does Aptose Biosciences employ?

people
Employees
36

What sector is Aptose Biosciences in?

pie chart
Sector
Health Care

Where is the head office for Aptose Biosciences?

location pin
Head Office
Toronto, Canada

What year was Aptose Biosciences founded?

founded flag
Year Founded
1986
What does Aptose Biosciences specialise in?
/Cancer Therapeutics /Clinical Development /Drug Discovery /Hematologic Malignancies /Pharmaceutical Research /Health Innovation

What are the products and/or services of Aptose Biosciences?

Overview of Aptose Biosciences offerings
Luxeptinib, a dual FLT3 and BTK inhibitor for acute myeloid leukemia and B-cell malignancies.
APTO-253, induces expression of the KLF4 gene, targeting acute myeloid leukemia and myelodysplastic syndromes.
Preclinical BTK inhibitors program targeting B-cell malignancies with a focus on overcoming resistance.
Preclinical FLT3 inhibitors program tailored for acute myeloid leukemia with a goal to evade current treatment resistance.
Collaborations with major pharmaceutical firms to enhance research, development, and commercialization of novel therapeutics.

Who is in the executive team of Aptose Biosciences?

Aptose Biosciences leadership team
  • Dr. William G. Rice Ph.D.
    Dr. William G. Rice Ph.D.
    Chairman, President, CEO & Chief Accounting Officer
  • Mr. Fletcher  Payne
    Mr. Fletcher Payne
    Senior VP, CFO, Chief Business Officer & Secretary
  • Dr. Rafael  Bejar M.D., Ph.D.
    Dr. Rafael Bejar M.D., Ph.D.
    Senior VP & Chief Medical Officer
  • Dr. Marc  Wiles Ph.D.
    Dr. Marc Wiles Ph.D.
    Senior Vice President of Regulatory Affairs
  • Mr. Brooks  Ensign M.B.A.
    Mr. Brooks Ensign M.B.A.
    VP & Controller